Central venous catheter type overview

central line

“This review gives a basic overview of the differences of CVC catheters including PICCs, Hickman-catheters and port-catheters along with the criteria for CVC selection” Kehagias et al (2023).

Catheter-related UEDVT recurrence in cancer patients

UEDVT

“Catheter-related thrombosis (CRT) occurs in approximately 2-6% of cancer patients. We conducted a single-center retrospective study to assess the rate of venous thromboembolism (VTE) recurrence in cancer patients; 200 patients were included” Hakem et al (2023).

Hemodialysis vascular access coordinator

vascular access

“The vascular access coordinator can positively contribute to increase the number of arteriovenous fistulas and reduce central venous catheters” Sousa et al (2023).

HAI bundle compliance results – Full Text

IVTEAM bundles

“Compliance rates were 94%, 100%, 99%, and 76% for ventilator-associated pneumonia, central line-associated bloodstream infections, catheter-associated urinary tract infections, and hand hygiene bundles, respectively” Alrebish et al (2023)

Vasopressor administration through a midline catheter

midline catheter

“We found no significant association of vasopressor administration though a midline with catheter-related complications. However, we identified an increased odds of systemic (but not ipsilateral upper extremity) venous thromboembolism warranting further evaluation” Gershengorn et al (2023).

Managing opioid waste in the emergency department

drug aministration

“In this study, we sought to utilize real-world data to describe the magnitude of morphine and hydromorphone waste in the studied EDs. We also applied scenario analyses based on provider ordering patterns to simulate the effects of cost versus opioid waste minimization when making purchasing decisions for the dose of stock vial of each opioid” Coleska et al (2023).

Central venous catheter material engineering

central line

“Long-term blood-contacting devices (e.g., central venous catheters, CVCs) still face the highest incidence of blood stream infection and thrombosis in clinical application. To effectively address these complications, this work reports a dual-functional surface engineering strategy for CVCs by organic integration of endothelium-mimicking and fibrinolytic functions” Li et al (2023).

IV iron infusion in patients with heart failure – Full Text

infusion

“Intravenous iron infusion in patients with HF reduces the composite risk of first hospitalization for HF and CV mortality as well as the risks of first and recurrent hospitalizations for HF, with no effect on all-cause mortality or CV mortality alone” Salah et al (2023).